Philippines - English - FDA (Food And Drug Administration)

nutrivet pharma, inc. - (multivitamins (ve.t) retinol palmitate (vit.a)/ cholecalciferol (vit.d3)/ dl-alpha-tocopheryl acetate (vit.e)/ thiamine hcl (vit.b1)/ riboflavin sodium phosphate (vit.b2)/ pyridoxine hcl) (vit.b6)/ cyanocobalamin (vit.b12)/ d-panthenol (vit.b5)/ nicotinamide (vit.pp) (vet.) - sterile solution for injection (im) - 15000iu/ 1000iu/ 20mg/ 10mg/ 5mg/ 3mg/ 50mcg/ 25mg/ 35mg per ml

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

basf australia ltd. - cholecalciferol - bait - cholecalciferol vitamin-d3 active 0.75 g/kg - vertebrate poison

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

the hunter river company pty limited - vitamin a palmitate; cholecalciferol; alpha-tocopheryl (vitamin e) - parenteral liquid/solution/suspension - vitamin a palmitate vitamin-a active 294.0 mg/ml; cholecalciferol vitamin-d3 active 1.25 mg/ml; alpha-tocopheryl (vitamin e) vitamin-e active 50.0 mg/ml - nutrition & metabolism

New Zealand - English - Ministry for Primary Industries

aotea ip holdings limited - cholecalciferol - cholecalciferol 8.07 g/kg - vertebrate toxic agent

New Zealand - English - Ministry for Primary Industries

animal control products limited trading as orillion - cholecalciferol - cholecalciferol 8 g/kg - vertebrate toxic agent

New Zealand - English - Ministry for Primary Industries

aotea ip holdings limited - cholecalciferol - cholecalciferol 4 g/kg - vertebrate toxic agent

United States - English - NLM (National Library of Medicine)

meda pharmaceuticals - cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41) - cholecalciferol 400 [iu]

United States - English - NLM (National Library of Medicine)

mayne pharma inc - vitamin a palmitate (unii: 1d1k0n0vvc) (vitamin a - unii:81g40h8b0t), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol (unii: h4n855pnz1) (.alpha.-tocopherol - unii:h4n855pnz1), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x5 - vitamin a 1500 [iu] in 1 ml - supplementation of the diet with eight essential vitamins and iron, plus fluoride. supplementation of the diet with fluoride for caries prophylaxis. the american academy of pediatrics recommends that children up to age 16, in areas where drinking water contains less than optimal levels of fluoride, receive daily fluoride supplementation. multi vitamin, iron and fluoride supplemental drops 0.25 provide fluoride in drop form for children ages 2-3 years where the drinking water contains less than 0.3 ppm of fluoride and for children over 3 years, in areas where the drinking water contains 0.3 through 0.7 ppm of fluoride. each 1.0 ml provides sodium fluoride (0.25 mg fluoride) plus eight essential vitamins and iron. the american academy of pediatrics and the american dental association currently recommend that infants and children under 2 years of age, in areas where drinking water contains less than 0.3 ppm of fluoride, and children 2-3, years of age, in areas where the drinking water contains 0.3 through 0.7

United States - English - NLM (National Library of Medicine)

sterling knight pharmaceuticals,llc - cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8) - cholecalciferol 5750 [iu] - revesta is indicated for dietary management of patients with unique nutritional needs requiring increased folate levels, vitamin d deficiency or are in need of vitamin d supplementation and other nutritional supplementation. this product is contraindicated in patients with a known hypersensitivity to any of the ingredients. revesta is contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin d, and hypervitaminosis d.

United States - English - NLM (National Library of Medicine)

adler-stern pharmaceuticals, llc - cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8) - cholecalciferol 3775 [iu] - ciferex is indicated for dietary management of patients with unique nutritional needs requiring increased folate levels, vitamin d deficiency or are in need of vitamin d supplementation and other nutritional supplementation. this product is contraindicated in patients with a known hypersensitivity to any of the ingredients. ciferex is contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin d, and hypervitaminosis d.